Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
| Publicado en: | Journal of Gastroenterology Vol. 59; no. 12; pp. 1119 - 1120 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180735582&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 180735582 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09441174 EJ7 jtl: Journal of Gastroenterology issn: 09441174 maglogo: N pubinfo: dt: Dec2024 vid: 59 iid: 12 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 180735582 180384697 10.1007/s00535-024-02159-y 180735582 ppf: 1119 ppct: 1 formats: tig: atl: Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study. aug: au: Ueno, Masayuki Takeda, Haruhiko Takai, Atsushi Morimura, Hiroki Nishijima, Norihiro Iwamoto, Satoru Okuyama, Shunsuke Umeda, Makoto Seta, Takeshi Ikeda, Atsuyuki Goto, Tomoyuki Miyamoto, Shin'ichi Kayahara, Takahisa Uenoyama, Yoshito Matsumura, Kazuyoshi Nakano, Shigeharu Mishima, Masako Inuzuka, Tadashi Eso, Yuji Takahashi, Ken affil: https://ror.org/02kpeqv85 Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan sug: pubtype: Academic Journal doctype: Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|